2023 Form 5500 filing — Acadia Pharmaceuticals 401(K) Plan And Trust
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241008130151NAL0029917104001) for Acadia Pharmaceuticals 401(K) Plan And Trust, reported by Acadia Pharmaceuticals, Inc. under EIN 06-1376651 and plan number 001. It reports 788 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241008130151NAL0029917104001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Acadia Pharmaceuticals, Inc.
- EIN
- 06-1376651
- Plan number
- 001
- Location
- San Diego, CA
- Participants
- 788
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $116,588,844
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $116,588,844
- Employer contributions
- $6,076,057
- Participant contributions
- $10,579,491
- Total income / additions
- $37,073,590
- Benefits paid
- $13,277,338
- Administrative expenses
- -$64,587
- Total expenses
- $13,212,751
- Net increase / (decrease)
- $23,860,839
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Resources Investment Advisors, LLC | INVESTMENT ADVISOR | $101,076 | not reported in the loaded dataset |
| Fidelity Investments Institutional | RECORDKEEPER | -$165,663 | $0 |